Cost-Effectiveness of Alemtuzumab In The Treatment of Relapsing Forms of Multiple Sclerosis In The United States and Societal Spillover Effects
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1942
https://www.valueinhealthjournal.com/article/S1098-3015(17)32276-3/fulltext
Title :
Cost-Effectiveness of Alemtuzumab In The Treatment of Relapsing Forms of Multiple Sclerosis In The United States and Societal Spillover Effects
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32276-3&doi=10.1016/j.jval.2017.08.1942
First page :
A722
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1768